PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Caris Life Sciences, 4610 South 44th Place, Phoenix, AZ, 85040, USA.\', \'Ruesch Center for the Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.\', \'Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.\', \'Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.\', \'University of Southern California, Keck School of Medicine, Norris Comprehensive Cancer Center, Los Angeles, CA, USA.\', \'Medical Oncology, West Cancer Center, 9745 Wolf River Blvd, Germantown, TN, USA.\', \'Caris Life Sciences, 4610 South 44th Place, Phoenix, AZ, 85040, USA. wmkorn@carisls.com.\', \'Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA. wmkorn@carisls.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-021-84731-7
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 33707526
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all